GIA announces the release of a comprehensive global report on Metabolomics market. The global market for metabolomics is forecast to reach $863.8 million by the year 2017, driven mainly by its increased efficacy and adoption in drug discovery and novel R&D processes. The metabolomics concept, considered to be in a relatively nascent stage of development, has nevertheless witnessed considerable growth over the last two decades. Increased levels of acceptance, technological advancements, greater investment inflows and surge of activity in the field of oncology biomarkers will push the expansion limits of metabolomics, making it a standard research tool in pharma and biotech sectors.
Download .pdf: Global-Metabolomics-Market-to-Reach-863.8 Million